Checkpoint inhibitor Sarcoma Carcinoma Monoclonal antibody Palliation Antibody Drug Conjugate (ADCs) Pathological stage Complete remission Adenocarcinoma CTACAE Cure Maintenance chemotherapy Complementary therapy TNM staging system ECOG performance status performance status Definitive treatment Minimal residual disease (MRD) Cellular therapy leukemia Recurrence Active surveillance Grade 3, 4, or 5 Neoadjuvant treatment Clinical stage Tyrosine kinase inhibitors (TKIs) Chemotherapy Relapse Partial Remission Surgical margin Maintenance chemotherapy Tumor Refractory Adjuvant treatment Checkpoint inhibitor Sarcoma Carcinoma Monoclonal antibody Palliation Antibody Drug Conjugate (ADCs) Pathological stage Complete remission Adenocarcinoma CTACAE Cure Maintenance chemotherapy Complementary therapy TNM staging system ECOG performance status performance status Definitive treatment Minimal residual disease (MRD) Cellular therapy leukemia Recurrence Active surveillance Grade 3, 4, or 5 Neoadjuvant treatment Clinical stage Tyrosine kinase inhibitors (TKIs) Chemotherapy Relapse Partial Remission Surgical margin Maintenance chemotherapy Tumor Refractory Adjuvant treatment
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Checkpoint inhibitor
Sarcoma
Carcinoma
Monoclonal antibody
Palliation
Antibody Drug Conjugate (ADCs)
Pathological stage
Complete remission
Adenocarcinoma
CTACAE
Cure
Maintenance chemotherapy
Complementary therapy
TNM staging system
ECOG performance status
performance status
Definitive treatment
Minimal residual disease (MRD)
Cellular therapy
leukemia
Recurrence
Active surveillance
Grade 3, 4, or 5
Neoadjuvant treatment
Clinical stage
Tyrosine kinase inhibitors (TKIs)
Chemotherapy
Relapse
Partial Remission
Surgical margin
Maintenance chemotherapy
Tumor
Refractory
Adjuvant treatment